119 related articles for article (PubMed ID: 16289138)
1. Differential regulation of anti-inflammatory proteins in human rheumatoid synoviocyte MH7A cell by celecoxib and ibuprofen.
Heum Park J; Cho Han D; Kim J; Hyung Hong S; Lee SK; Seog Yoon K; Min Kim J; Son KH; Miyazawa K; Kwon BM
Life Sci; 2006 Apr; 78(19):2204-12. PubMed ID: 16289138
[TBL] [Abstract][Full Text] [Related]
2. Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells.
Lev-Ari S; Strier L; Kazanov D; Elkayam O; Lichtenberg D; Caspi D; Arber N
Rheumatology (Oxford); 2006 Feb; 45(2):171-7. PubMed ID: 16249246
[TBL] [Abstract][Full Text] [Related]
3. Differential up-regulation of cytosolic and membrane-bound heat shock protein 70 in tumor cells by anti-inflammatory drugs.
Gehrmann M; Brunner M; Pfister K; Reichle A; Kremmer E; Multhoff G
Clin Cancer Res; 2004 May; 10(10):3354-64. PubMed ID: 15161689
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the effectiveness of selected non-steroidal anti-inflammatory drugs and their derivatives against cancer cells in vitro.
Andrews P; Zhao X; Allen J; Li F; Chang M
Cancer Chemother Pharmacol; 2008 Feb; 61(2):203-14. PubMed ID: 17447067
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of 150-kDa oxygen-regulated protein by celecoxib in human gastric carcinoma cells.
Namba T; Hoshino T; Tanaka K; Tsutsumi S; Ishihara T; Mima S; Suzuki K; Ogawa S; Mizushima T
Mol Pharmacol; 2007 Mar; 71(3):860-70. PubMed ID: 17167033
[TBL] [Abstract][Full Text] [Related]
6. Celecoxib transiently inhibits cellular protein synthesis.
Pyrko P; Kardosh A; Schönthal AH
Biochem Pharmacol; 2008 Jan; 75(2):395-404. PubMed ID: 17920040
[TBL] [Abstract][Full Text] [Related]
7. The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials.
Soni P; Shell B; Cawkwell G; Li C; Ma H
Curr Med Res Opin; 2009 Aug; 25(8):1841-51. PubMed ID: 19530981
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory drugs suppress proliferation and induce apoptosis through altering expressions of cell cycle regulators and pro-apoptotic factors in cultured human osteoblasts.
Chang JK; Li CJ; Liao HJ; Wang CK; Wang GJ; Ho ML
Toxicology; 2009 Apr; 258(2-3):148-56. PubMed ID: 19428934
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
Liu B; Shi ZL; Feng J; Tao HM
Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766
[TBL] [Abstract][Full Text] [Related]
10. Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis.
Becker MC; Wang TH; Wisniewski L; Wolski K; Libby P; Lüscher TF; Borer JS; Mascette AM; Husni ME; Solomon DH; Graham DY; Yeomans ND; Krum H; Ruschitzka F; Lincoff AM; Nissen SE;
Am Heart J; 2009 Apr; 157(4):606-12. PubMed ID: 19332185
[TBL] [Abstract][Full Text] [Related]
11. Guaifenesin enhances the analgesic potency of ibuprofen, nimesulide and celecoxib in mice.
Sliva J; Dolezal T; Sykora D; Vosmanska M; Krsiak M
Neuro Endocrinol Lett; 2009; 30(3):352-6. PubMed ID: 19855358
[TBL] [Abstract][Full Text] [Related]
12. Proteomic profiling identifies cyclooxygenase-2-independent global proteomic changes by celecoxib in colorectal cancer cells.
Lou J; Fatima N; Xiao Z; Stauffer S; Smythers G; Greenwald P; Ali IU
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1598-606. PubMed ID: 16985019
[TBL] [Abstract][Full Text] [Related]
13. [Effects of nonsteroidal anti-inflammatory drug celecoxib on expression of cyclooxygenase-2 (COX-2) in ovarian carcinoma cell].
Wang HJ; Liu XJ; Yang KX; Luo FM; Lou JY; Peng ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):757-60. PubMed ID: 17037745
[TBL] [Abstract][Full Text] [Related]
14. GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells.
Kim SH; Hwang CI; Juhnn YS; Lee JH; Park WY; Song YS
Carcinogenesis; 2007 Jan; 28(1):223-31. PubMed ID: 17166886
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells.
Sakoguchi-Okada N; Takahashi-Yanaga F; Fukada K; Shiraishi F; Taba Y; Miwa Y; Morimoto S; Iida M; Sasaguri T
Biochem Pharmacol; 2007 May; 73(9):1318-29. PubMed ID: 17270149
[TBL] [Abstract][Full Text] [Related]
16. Antiatherosclerotic activity of ibuprofen, a non-selective COX inhibitor--an animal study.
Dabhi JK; Solanki JK; Mehta A
Indian J Exp Biol; 2008 Jun; 46(6):476-81. PubMed ID: 18697608
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
Huang WF; Hsiao FY; Wen YW; Tsai YW
Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
[TBL] [Abstract][Full Text] [Related]
18. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S
Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib inhibits interleukin-12 alphabeta and beta2 folding and secretion by a novel COX2-independent mechanism involving chaperones of the endoplasmic reticulum.
Alloza I; Baxter A; Chen Q; Matthiesen R; Vandenbroeck K
Mol Pharmacol; 2006 May; 69(5):1579-87. PubMed ID: 16467190
[TBL] [Abstract][Full Text] [Related]
20. Pattern recognition analysis for the prediction of adverse effects by nonsteroidal anti-inflammatory drugs using 1H NMR-based metabolomics in rats.
Um SY; Chung MW; Kim KB; Kim SH; Oh JS; Oh HY; Lee HJ; Choi KH
Anal Chem; 2009 Jun; 81(12):4734-41. PubMed ID: 19462990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
